Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
9.54
+0.02 (0.21%)
Dec 24, 2024, 1:00 PM EST - Market closed
Astria Therapeutics Market Cap
Astria Therapeutics has a market cap or net worth of $538.38 million as of December 24, 2024. Its market cap has increased by 188.06% in one year.
Market Cap
538.38M
Enterprise Value
199.74M
1-Year Change
188.06%
Ranking
Category
Stock Price
$9.54
Market Cap Chart
Since June 25, 2015, Astria Therapeutics's market cap has increased from $180.00M to $538.38M, an increase of 199.10%. That is a compound annual growth rate of 12.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2024 | 538.40M | 93.11% |
| Dec 29, 2023 | 278.80M | 11.30% |
| Dec 30, 2022 | 250.50M | 257.35% |
| Dec 31, 2021 | 70.10M | 63.02% |
| Dec 31, 2020 | 43.00M | -38.31% |
| Dec 31, 2019 | 69.70M | 124.84% |
| Dec 31, 2018 | 31.00M | -9.88% |
| Dec 29, 2017 | 34.40M | -48.89% |
| Dec 30, 2016 | 67.30M | -44.52% |
| Dec 31, 2015 | 121.30M | -32.61% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fulgent Genetics | 560.96M |
| Annexon | 557.48M |
| SI-BONE | 555.68M |
| OrthoPediatrics | 541.95M |
| Pacific Biosciences of California | 539.51M |
| Ginkgo Bioworks Holdings | 535.07M |
| Opthea | 531.21M |
| Tourmaline Bio | 529.52M |